Related Experiment Videos

[Recurrent pneumothorax in a child with Langerhans' cell histiocytosis]

H Bubała1, D Sońta-Jakimczyk, J Gregor

  • 1Katedry i Kliniki Hematologii Dzieciecej i Chemioterapii Sl. A.M. w Zabrzu.

Insights

A 16-month-old boy developed pneumothorax and lung infiltrations, initially thought inflammatory. Diagnosis revealed Langerhans cell histiocytosis, a rare condition requiring specific treatment.

Area of Science:

  • Pediatric Pulmonology
  • Pediatric Oncology
  • Histiocytosis

Background:

  • Langerhans cell histiocytosis (LCH) is a rare clonal proliferative disorder of Langerhans-related cells.
  • LCH can affect multiple organs, including the lungs, and may present with diverse clinical manifestations.

Observation:

  • A previously healthy 16-month-old boy presented with acute right-sided pneumothorax and bilateral lung infiltrations.
  • Initial management with pleural drainage and antibiotics led to temporary improvement, but recurrent pneumothorax and persistent lung changes suggested an underlying condition.
  • Histopathological examination following minithoracotomy confirmed Langerhans cell histiocytosis.

Findings:

  • The patient developed symptoms of diabetes insipidus, a known complication of LCH affecting the pituitary stalk.
  • Treatment was initiated using a modified chemotherapy program (DAL-HX83/90).
  • Despite treatment aimed at remission, the patient experienced two further episodes of pneumothorax.

Implications:

  • This case highlights the importance of considering rare diagnoses like LCH in pediatric patients with recurrent respiratory symptoms and infiltrates.
  • Early recognition and appropriate treatment are crucial for managing LCH and its complications, such as pneumothorax and diabetes insipidus.
  • Multidisciplinary management is essential for optimizing outcomes in pediatric LCH patients.

Related Concept Videos